Study on the Changes and Correlation of Related Immune Factors before and after Chemotherapy in Non-Small Cell Lung Cancer
- 1 Department of Oncology, The Affiliated Hospital of Chengde Medical University, Chengde, China
- 2 Department of Urology, The Affiliated Hospital of Chengde Medical University, Chengde, China
- 3 Department of Oncology, The Affiliated Hospital of Chengde Medical University, Chengde, China
- 4 Department of Oncology, The Affiliated Hospital of Chengde Medical University, Chengde, China
- 5 Department of Oncology, The Affiliated Hospital of Chengde Medical University, Chengde, China
- 6 Department of Oncology, The Affiliated Hospital of Chengde Medical University, Chengde, China
- 7 Department of Oncology, The Affiliated Hospital of Chengde Medical University, Chengde, China
- 8 Department of Oncology, The Affiliated Hospital of Chengde Medical University, Chengde, China
- 9 Department of Oncology, The Affiliated Hospital of Chengde Medical University, Chengde, China
- 10 Department of Oncology, The Affiliated Hospital of Chengde Medical University, Chengde, China
Abstract
Objective: To investigate the changes of related immune cytokines (Dendritic Cells (DC) cells, CD4 + , CD8 + , Th17, IgG, IgM, IgA) in patients with non-small cell lung cancer (NSCLC) before and after chemotherapy. Methods: Eighty-five NSCLC patients who were treated in the Oncology Department of the Affiliated Hospital of Chengde Medical College from December 2018 to February 2021 were selected as the research objects, and the patients were analyzed at different time points (before chemotherapy, after the first chemotherapy, and after the second chemotherapy) Changes in the expression levels of DC cells, CD4 + , CD8 + , Th17, IgG, IgM, IgA in peripheral blood, and explore their correlation. Results: Before chemotherapy, after the first chemotherapy, and after the second chemotherapy, the peripheral blood CD4 + and CD8 + were significantly increased, and the Th17, IgG, IgM, and IgA levels gradually decreased. The difference was statistically significant. But there was no obvious change in DC cells. Conclusion: There is no significant change in DC cells in peripheral blood of NSCLC patients before and after chemotherapy. CD4 + and CD8 + are significantly increased, Th17, IgG, IgM, and IgA levels are all decreased, which is a manifestation of impaired immune function of patients after chemotherapy.
- Wang, N., Mengersen, K., Tong, S., et al. (2019) Lung Cancer Mortality in China: Spatial and Temporal Trends Among Subpopulations. Chest, 156, 972-983.
- Li, L. and Li, M. (2019) Progress in Diagnosis and Treatment of Stage IA Lung Cancer. Chinese Journal of Practical Internal Medicine, 39, 420-424.
- Deng, T., Tang, J., Zhou, L., et al. (2019) Effective Targeted Therapy Based on Dynamic Monitoring of Gene Mutations in Non-Small Cell Lung Cancer. Translational Lung Cancer Research, 8, 532-538.
- Zeng, W.Q., Feng, W., Xie, L., et al. (2019) Postoperative Radiotherapy for Resected Stage IIIA-N2 Non-Small-Cell LUNG Cancer: A Population-Based Time-Trend Study. Lung, 197, 741-751. https://doi.org/10.1007/s00408-019-00284-7
- Li, H. (2017) Thoughts from Reading the Eighth Edition of the AJCC Lung Cancer Staging System. Chinese Journal of Surgery, 55, 346-350.
- Wang, Q.M. (2017) New Perspectives and New Thinking on Lung Cancer Chemotherapy under the Background of Precision Medicine. Journal of Medical Postgraduates, 30, 1151-1154.
- Fan, G.H., Xu, X.X., Chen, Y., et al. (2016) A Comparative Study of Transcutaneous Electrical Nerve Stimulation and Acupoint Pressing Combined with Moxibustion on Reducing Gastrointestinal Reactions in Patients with Lung Cancer after Chemotherapy with Cisplatin Regimen. Chinese Journal of Lung Diseases (Electronic Edition), 6, 41-45.
- Riley, R.S., June, C.H., Langer, R., et al. (2019) Delivery Technologies for Cancer Immunotherapy. Nature Reviews Drug Discovery, 18, 175-196. https://doi.org/10.1038/s41573-018-0006-z
- Ribas, A. and Wolchok, J.D. (2018) Cancer Immunotherapy Using Checkpoint Blockade. Science, 359, 1350-1355. https://doi.org/10.1126/science.aar4060
- Nam, J., Son, S., Park, K.S., et al. (2019) Cancer Nanomedicine for Combination Cancer Immunotherapy. Nature Reviews Materials, 4, 398-414. https://doi.org/10.1038/s41578-019-0108-1
- Leone, R.D. and Emens, L.A. (2018) Targeting Adenosine for Cancer Immunotherapy. Journal for Immunotherapy of Cancer, 6, 1-9.
- Sahin, U. and Türeci, Ö. (2018) Personalized Vaccines for Cancer Immunotherapy. Science, 359, 1355-1360.
- Hegde, P.S. and Chen, D.S. (2020) Top 10 Challenges in Cancer Immunotherapy. Immunity, 52, 17-35.
- Goldberg, M.S. (2019) Improving Cancer Immunotherapy through Nanotechnology. Nature Reviews Cancer, 19, 587-602.